Current approach to eating disorders: a clinical update
Glucagon-like peptide-1 receptor activation maintains extracellular matrix integrity by inhibiting the activity of mitogen-activated protein kinases and activator protein-1
Liraglutide = LIR a GLOO tide LIR, like a Learjet Uh, which is a short A sound or a schwa A sound
Critically, the limitations of conventional cancer therapies-including efficacy-toxicity tradeoffs and therapeutic resistance-highlight an urgent need for innovative approaches where bioelectromagnetic strategies may offer transformative potential
For patients where heart disease is the primary concern alongside weight, the cardiovascular trial evidence behind Wegovy is currently more developed
The FDA has approved Zepbound for use with diet and exercise in adults with a body mass index (BMI) of: 30 or higher (obesity), or 27 or higher with a weight-related health condition, such as high blood pressure, high cholesterol, type 2 diabetes, sleep apnea, or heart disease
